Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-25

Clinical Trial Update: Rotavirus Vaccine Produced by Butantan Institute [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of a rotavirus vaccine produced by the Butantan Institute has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotavirus vaccine (Butantan Institute) (rotavirus vaccine)

Snippet

Sponsor: Butantan Institute | Conditions: Rotavirus Infections | Phase 1 | Status: COMPLETED | Results posted: 2013-04-25